{"id":"W2746712977","doi":"10.1016/j.ctrv.2017.08.001","title":"Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Hazard ratio; Internal medicine; Breast cancer; Oncology; Meta-analysis; Confidence interval; Randomized controlled trial; Odds ratio; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008751426,0.002386588,0.01455406,0.001911459,0.0002935331,0.002102425,0.001802191,0.001741353,0.00362258],"category_scores_gemma":[0.01864178,0.001167905,0.02505667,0.003045537,0.0005210633,0.001521322,0.001092678,0.002654222,0.0002440822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001752344,"about_ca_system_score_gemma":0.001586897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003632212,"about_ca_topic_score_gemma":0.008688467,"domain_scores_codex":[0.9952986,0.002233414,0.001228285,0.0005985443,0.0004492731,0.0001918759],"domain_scores_gemma":[0.9888701,0.008931776,0.001389629,0.0003046387,0.0003520647,0.0001517752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01188754,0.00004398453,0.002734204,0.259045,0.6920743,0.00008904095,0.00007235078,0.000779559,0.0004153435,0.0001925426,0.001093131,0.03157289],"study_design_scores_gemma":[0.00261112,0.0004031855,0.003873515,0.01002405,0.9796719,0.00007616852,0.00003637495,0.0001461456,0.0001225614,0.0003601475,0.002649253,0.00002552879],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003145374,0.9960508,0.0002668576,0.00008057368,0.0001039778,0.00005089939,0.0001717399,0.00001228129,0.0001175427],"genre_scores_gemma":[0.1167808,0.8793148,0.001504766,0.0008768502,0.0002668827,0.0002397956,0.0005918522,0.00003312948,0.0003910934],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01455406,"threshold_uncertainty_score":0.04628247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4789733859490883,"score_gpt":0.54750043717925,"score_spread":0.06852705123016167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}